Public health impact and treatment of insomnia

European Psychiatry

Volumn 12, Issue SUPPL. 1, 1997, Pages 31-39

  Dement, W C ^a   Pelayo, R ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Epidemiology; Hypnotics; Insomnia; Public health; Sleep disorders; Therapeutics

Indexed keywords

DIAZEPAM; ESTAZOLAM; FLURAZEPAM; HYPNOTIC AGENT; LORAZEPAM; TEMAZEPAM; TRANQUILIZER; TRIAZOLAM; ZOLPIDEM; ZOLPIDEM TARTRATE;

BEHAVIOR THERAPY; COST; DRUG THERAPY; HUMAN; INSOMNIA; PRIORITY JOURNAL; PUBLIC HEALTH; RESEARCH; REVIEW; SLEEP DISORDER; UNITED STATES;

EID: 0031020888     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0924-9338(97)80018-1     Document Type: Review

References (41)

1. Atlas Task Force. Recording and scoring leg movements. Sleep 1993; 16 (8):748-59
2. Bartholini C. Growing aspects of hypnotic drugs. In: Sauvanet IP et al, eds. Imidiazopyridincs in Sleep Disorders. New York: Raven Press, 1988:1-9
3. Besset A, Tafti M, Villemin E, Borderies P, Billiard M. Effects of zolpidem on the architecture and cyclical structure of sleep in poor sleepers. Drugs Exp Clin Res 1995;2 (4):161-9
4. Bliwise DL. Treating insomnia: pharmacological and nonpharmacological approaches. J Psychoactive Drugs 1991;23(4):335-41
5. Brooks JO 3d, Friedman L, Bliwise DL, Yesavage JA. Use of the wrist actigraph to study insomnia in older adults. Sleep 1993;16 (2):151-5
6. Chambers MJ. Actigraphy and insomnia: a closer look. Sleep 1994;7 (5):405-8
7. Czeisler CA, Allan JS, Stogatz et al. Bright light resets the human circadian pacemaker independent of the sleepwake cycle. Science 1986;233:667-71
8. Diagnostic Classification Steering Committee, Thorpy MJ, Chairman. International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, Minnesota: American Sleep Disorders Association, 1990
9. Ferber RA. Solve your Child's Sleep Problem. New York: Simon and Schuster, 1985
10. Gallup Organization: Sleep in America: a National Survey of US Adults. Princeton, NJ, 1991
11. Gallup Organization. Doctors' (300) Experience and Behavior with Insomnia Patients. The Gallup Organization, 1993:1-97
12. Gallup Organization. Sleep in America: 1995. The Gallup Organization, November, 1995
13. Gillin JC, Spinweber CL, Johnson LC. Rebound insomnia: a critical review. J Clin Psychopharmacol 1989;9:161-72
14. Guilleminault C, Clerk A, Black J et al. Non-drug treatment trials in psychophysiologic insomnia. Arch Intern Med 1995;155(8):838-44
15. Haimov I, Lavie P, Laudon M et al. Melatonin replacement therapy of elderly insomniacs. Sleep 1995;18(7):598-603
16. Hauri PJ, Wisbey J. Wrist actigraphy in insomnia. Sleep 1992;15 (4):293-301
17. Hohagen F, Rink K, Kappler C et al. Prevalence and treatment of insomnia in general practice. A longitudinal study. Euro Arch Psychiatry Clin Neurosci 1993; 242 (6):329-36
18. Jan JE, Espezel H, Appleton RE. The treatment of sleep disorders with melatonin. Dev Med Child Neurol 1994;36(2):97-107
19. Kaplan PW, Allen RP, Buchholz DW, Walters JK. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 1993;16 (8):717-23
20. Medical Letter. The Melatonin. 1995;37(962):111-12
21. Merlotti L, Roehrs T, Zorick F, Roth T. Rebound insomnia: duration of use and individual differences. J Clin Psychopharm 1991;11 (6):368-73
22. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994;151:1172-80
23. National Commission on Sleep Disorders Research: Wake up America. Dement WC, Chairman. Washington, DC: National Institute of Health, 1993
24. O'Keeffe ST, Noel J, Lavan JN. Restless legs syndrome in the elderly. Postgrad Med J 1993;69(815):701-3
25. Oboler SK, Prochazka AV, Meyer TJ. Leg symptoms in outpatient veterans. West J Med 1991;155(3):256-9
26. Ohayon M, Caulet M. Insomnia and psychotropic drug consumption. Prog Neuropsychopharmacol Biol Psychiatry 1995;19(3):421-31
27. Partinen M. Epidemiology of sleep disorders. In: Kryger M, Roth T, Dement WC, eds. Principals and Practice of Sleep Medicine. Philadelphia: WB Saunders, 1994:426-36
28. Pillitteri JL, Kozlowski LT, Person DC, Spear ME. Over-the-counter sleep aids: widely used but rarely studied. J Subst Abuse 1994;6(3):315-23
29. Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. Sleep 1995;18 (4):285-7
30. Practice parameters for the use of polysomnography in the evaluation of insomnia. Sleep 1995;18 (1):55-7
31. Radecki SE, Brunton SA. Management of insomnia in office-based practice. National prevalence and therapeutic patterns. Arch Family Med 1993;2 (11):1129-34
32. Reite M, Buysse D, Reynolds C, Mendelson W. The use of polysomnography in the evaluation of insomnia. Standards of Practice Committee, American Sleep Disorders Association. Sleep 1995; 18 (1):58-70
33. Roehrs T, Merlotti L, Zorick F, Roth T. Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation. Psychopharmacology 1992;108:67-71
34. Rosekind MR. The epidemiology and occurrence of insomnia. J Clin Psychiatry 1992;53(suppl):4-6
35. Roth T, Roehrs T, Vogel G. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. Sleep 1995;18(4):246-51
36. Sadeh A, Hauri PJ, Kripke DF, Lavie P. The role of actigraphy in the evaluation of sleep disorders. Sleep 1995;18(4):288-302
37. Shorr RI, Bauwens SF. Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians. Am J Med 1992; 193(1):78-82
38. Sloan EP, Hauri P, Bootzin R, Morin C, Stevenson M, Shapiro CM. The nuts and bolts of behavioral therapy for insomnia. J Psychosom Res 1993;37(suppl 1):19-37
39. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987;10(1):45-56
40. Stoller MK. Economic effects of insomnia. Clin Ther 1994;16:873-96
41. Young T, Palta M, Dempsey J et al. Occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993;328: 1230-35